Results overview: Found 2 records in 0.01 seconds.
Articles, 2 records found
Articles 2 records found  
1.
12 p, 524.6 KB Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells / Huyveneers, Laura E. P. (University Medical Center Utrecht) ; Bruns, Anke (University Medical Center Utrecht) ; Stam, Arjen (University Medical Center Utrecht) ; Ellerbroek, Pauline (University Medical Center Utrecht) ; de Jong, Dorien (University Medical Center Utrecht) ; Nagy, Noémi A. (University Medical Center Utrecht) ; Gumbs, Stephanie B. H. (University Medical Center Utrecht) ; Tesselaar, Kiki (University Medical Center Utrecht) ; Bosman, Kobus (University Medical Center Utrecht) ; Salgado, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Hütter, Gero (DKMS CC) ; Brosens, Lodewijk A. A. (University Medical Center Utrecht) ; Kwon, Mi (Hospital General Universitario Gregorio Marañón) ; Diez Martin, Jose (Hospital General Universitario Gregorio Marañón) ; van der Meer, Jan T. M. (Amsterdam UMC) ; de Kort, Theun M. (Leiden University Medical Center) ; Sáez-Cirión, Asier (Université Paris Cité) ; Schulze zur Wiesch, Julian (UMC Hamburg-Eppendorf) ; Boelens, Jaap Jan (Memorial Sloan Kettering Cancer Center) ; Martínez Picado, Francisco Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Kuball, Jurgen (University Medical Center Utrecht) ; Wensing, Annemarie M. J. (University Medical Center Utrecht) ; Nijhuis, Monique (University Medical Center Utrecht)
Allo-HSCT with CCR5Δ32/Δ32 donor cells is the only curative HIV-1 intervention. We investigated the impact of allo-HSCT on the viral reservoir in PBMCs and post-mortem tissue in two patients. IciS-05 and IciS-11 both received a CCR5Δ32/Δ32 allo-HSCT. [...]
2022 - 10.3390/v14092069
Viruses, Vol. 14 (september 2022)  
2.
13 p, 1.1 MB A strategic reflection for the management and implementation of CAR-T therapy in Spain : an expert consensus paper / Zozaya, Néboa (Universidad de Las Palmas de Gran Canaria) ; Villaseca Carmena, Javier (Weber Economía y Salud) ; Abdalla, Fernando (Weber Economía y Salud) ; Calleja Hernández, Miguel Ángel (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Díez-Martín, José Luis (Universidad Complutense de Madrid) ; Estévez, Joaquín (Sociedad Española de Directivos de La Salud) ; García-Sanz, Ramón (Instituto de Investigación Biomédica de Salamanca) ; Martínez-López, Joaquín (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Vera, Ruth (Complejo Hospitalario de Navarra) ; Hidalgo, Álvaro (Universidad de Castilla-La Mancha) ; Universitat Autònoma de Barcelona
CAR-T cell therapy represents a therapeutic revolution in the prognosis and treatment of patients with certain types of hematological cancer. However, they also pose new challenges in the healthcare, regulatory and financial fields. [...]
2022 - 10.1007/s12094-021-02757-9
Clinical & Translational Oncology, january 2022, p. 1-13  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.